Vir Biotechnology shares lost 30.4% on August 7, 2025, against a gain in the S&P 500.
1 report, 1 independent
Updated Aug 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Vir Biotechnology shares lost 30.4% on August 7, 2025, against a gain in the S&P 500.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
VIR Biotechnology
biotech company
Nothing else this week.
Coverage
Newest first; wire copies grouped- ZacksVir Biotechnology, Inc. (VIR) Reports Q2 Loss, Lags Revenue Estimates Vir Biotechnology, Inc. (VIR) came out with a quarterly loss of $0.8 per share versus the Zacks Consensus Estimate of a loss of $